PRACTICE Guidelines REGISTRATION PLATFORM
News MORE
  • 2023.0306

    The Development of Reporting Guideline of clinical Practice Guidelines in General Practice provides detailed guidance for the makers and writers of the general practice guidelines, which will further improve the reporting quality of the general practice guidelines, especially the Chinese general practice guidelines, and promote the application in general medical practice, thus finally improving the quality of primary medical care.

  • 2023.0220

    Professor Gordon Guyatt of McMaster University and Professor Victor Montori of the Mayo Clinic jointly published a paper in the British Medical Journal (BMJ) entitled: Guidelines should consider clinicians' time needed to treat on January 3, 2023.

  • 2022.1126

    IGEST is a generic tool for screening guidelines for any specialty, target population, and healthcare organization, but it is intended only as a screening tool, primarily for quickly assessing guideline quality and determining whether they can be adopted or adapted in other settings, and is not a substitute for some of the more complex guideline quality evaluation tools.

  • 2022.1031

    In July 2022, Jose F. Meneses-Echavez et al. from the Norwegian Institute of Public Health published an article in the Journal of Clinical Epidemiology entitled "Evidence to decision frameworks enabled structured and explicit development of healthcare recommendations". The aim of this study was to identify and describe the processes suggested for the formulation of healthcare recommendations in healthcare guidelines available in guidance documents.

Register MORE
  • 2024.0509
    Placenta accreta spectrum (PAS) disorders pose a grave threat to maternal life due to severe hemorrhage and the heightened risk of peripartum hysterectomy. Accurate diagnosis of PAS during pregnancy can significantly improve outcomes. Currently, ultrasound serves as the main diagnostic method for PAS. This expert consensus aims to provide guidance based on current evidence-based medicine on key issues related to ultrasound diagnosis of PAS, to promote the standardized and effective application of ultrasound in PAS diagnosis.
  • 2024.0508
    Currently, there are no standardised criteria for the standardised operation of neurophysiological monitoring, data collection and analysis of results. Most NICU units are still in a gap in the application of neurophysiological monitoring, and there is also an urgent need for guidance and standardisation in the application of neurophysiological monitoring in NICUs. Therefore, in order to solve this problem, this expert consensus was formulated under the premise of extensive consultation.
  • 2024.0507
    Abnormal skin wound healing resulting from trauma, such as burns or injuries, is the primary etiology of pathological scars in pediatric patients. Pathological scars not only impact appearance and function but also impede normal physical and psychological development due to the unique physiological structure and developmental potential of children's skin. Given the variations in developmental potential among children of different ages, compared to adults, greater caution is required when devising prevention and treatment strategies for pediatric pathological scars, leading to numerous controversies in this field. On one hand, children possess a robust ability to heal skin wounds; thus proper wound management and healing processes can aid in reducing the formation of pathological scars. On the other hand, due to organ immaturity in children, conflicts between treatment methods/timing and developmental needs may exacerbate scar formation and functional impairment. Consequently, prevention and treatment approaches for pediatric pathological scars exhibit distinctive characteristics. Currently, there exists no consensus on these strategies both domestically and internationally. Therefore, we have collaborated with domestic experts in relevant fields to develop this consensus aiming at providing guidance for preventing and treating pediatric pathological scars.
  • 2024.0507
    The coexistence of thyroid nodules in breast cancer patients is widely observed, impacting the treatment and prognosis of breast cancer patients. In long-term survival cases of early-stage breast cancer, there is a notable high incidence of accompanying thyroid nodules, a trend that has gained increasing attention in recent years. Currently, there is a lack of consensus or guidelines regarding the diagnosis and treatment of thyroid nodules in breast cancer patients.Based on the guideline / expert consensus and the clinical experience of multiple medical centers, the Society of Breast Cancer Integration and Rehabilitation of China Anti-Cancer Association, in collaboration with the Chongqing Federation of Clinical Medical Research, Committee of Thyroid Disease of Chongqing Society of Integrated Traditional Chinese and Western Medicine, and the Society of Onco-endocrinology of Chongqing Anti-Cancer Association, has organized relevant experts to extensively discuss and formulate the "Chinese expert consensus recommendations for management of thyroid nodules in breast cancer women (2024 edition)", aiming to standardize the management of thyroid nodules in breast cancer women.
Registration process and operational mode of a CPG registry